$158.78
1.43% today
Nasdaq, Feb 28, 04:49 pm CET
ISIN
US7599161095
Symbol
RGEN

Repligen Corporation Stock price

$156.54
-11.47 6.83% 1M
+10.51 7.20% 6M
+12.60 8.75% YTD
-36.17 18.77% 1Y
-40.16 20.42% 3Y
+70.44 81.81% 5Y
+130.83 508.87% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-6.27 3.85%
ISIN
US7599161095
Symbol
RGEN
Sector
Industry

Key metrics

Market capitalization $8.77b
Enterprise Value $8.74b
P/E (TTM) P/E ratio negative
EV/Sales (TTM) EV/Sales 13.78
P/S ratio (TTM) P/S ratio 13.82
P/B ratio (TTM) P/B ratio 4.35
Revenue growth (TTM) Revenue growth 0.33%
Revenue (TTM) Revenue $634.44m
EBIT (operating result TTM) EBIT $24.28m
Cash position $757.36m
EPS (TTM) EPS $-0.46
P/E forward 172.78
P/S forward 12.59
EV/Sales forward 12.56
Short interest 6.90%
Show more

Is Repligen Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Repligen Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Repligen Corporation forecast:

13x Buy
68%
6x Hold
32%

Analyst Opinions

19 Analysts have issued a Repligen Corporation forecast:

Buy
68%
Hold
32%

Financial data from Repligen Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
634 634
0% 0%
100%
- Direct Costs 346 346
1% 1%
55%
289 289
1% 1%
45%
- Selling and Administrative Expenses 139 139
32% 32%
22%
- Research and Development Expense 42 42
0% 0%
7%
107 107
22% 22%
17%
- Depreciation and Amortization 82 82
4% 4%
13%
EBIT (Operating Income) EBIT 24 24
52% 52%
4%
Net Profit -26 -26
172% 172%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Repligen Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Repligen Corporation Stock News

Neutral
Seeking Alpha
8 days ago
Repligen Corporation (NASDAQ:RGEN ) Q4 2024 Earnings Call Transcript February 20, 2025 8:30 AM ET Company Participants Sondra Newman - Global Head of Investor Relations Olivier Loeillot - President and Chief Executive Officer Jason Garland - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Rachel Vatnsdal - J.P. Morgan Puneet Souda - Leerink Partners Matt Larew - William ...
Positive
The Motley Fool
8 days ago
Repligen (RGEN 7.92%), a bioprocessing technology company, announced its earnings for the fourth quarter on Feb. 20. Its adjusted earnings per share (EPS) of $0.44 exceeded analysts' consensus estimate of $0.41, but fell year over year.
Neutral
GlobeNewsWire
17 days ago
Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ET Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ET
More Repligen Corporation News

Company Profile

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Head office United States
CEO Olivier Loeillot
Founded 1981
Website www.repligen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today